<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00406913</url>
  </required_header>
  <id_info>
    <org_study_id>14208B</org_study_id>
    <nct_id>NCT00406913</nct_id>
  </id_info>
  <brief_title>Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery</brief_title>
  <official_title>Assessment of Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery Using Intranasal Mupirocin Ointment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the conjunctival flora prior to cataract or
      vitrectomy surgery comparing mupirocin ointment applied to the conjunctiva along with
      standard ocular sterilization vs. standard ocular sterilization alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bacterial endophthalmitis is a rare but devastating complication of intraocular surgery.
      Given the devastating ocular sequelae of endophthalmitis, one cannot underestimate the need
      to develop a sterilization strategy which most effectively prevents intraocular infection.
      The most common organisms causing bacterial postoperative endophthalmitis are gram-positive
      cocci, particularly coagulase-negative staphylococci and Staphylococcus Aureus. It is thought
      that the most common sources of bacterial contamination predisposing to endophthalmitis are
      the eyelids and conjunctiva (Ariyasu).

      The two main techniques used to reduce the bacterial flora on the ocular surface include
      treatment of the ocular surface with topical antibiotics prior to surgery and the
      instillation of 5% povidone-iodine during the prep immediately prior to beginning the
      surgical procedure (Speaker). Mupirocin ointment is a logical choice for surgical prophylaxis
      as it has been reported that mupirocin treatment applied to the nose resulted in elimination
      rates (of S. Aureus from the nares) of 91% directly after therapy (Doebbeling). Use of
      mupirocin ointment applied to the nares prior to eye surgery resulted in a significant
      decrease in the bacterial load on the conjunctiva at the time of surgery (Alexandrou, in
      press). Using mupirocin ointment directly to the conjunctiva, in addition to standard ocular
      sterilization techniques, may result in an even greater decrease in conjunctival flora prior
      to eye surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <primary_completion_date type="Actual">November 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive conjunctival culture</measure>
    <time_frame>pre and post op</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Endophthalmitis</condition>
  <condition>Cataract Surgery</condition>
  <condition>Prophylaxis</condition>
  <arm_group>
    <arm_group_label>Mupirocin ointment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care sterilization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>mupirocin ointment</intervention_name>
    <arm_group_label>Mupirocin ointment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SOC sterilization</intervention_name>
    <arm_group_label>Mupirocin ointment</arm_group_label>
    <arm_group_label>Standard of Care sterilization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Included in the study will be any patient eligible for cataract or vitrectomy surgery.
             No populations will be excluded on the basis of demographics.

        Exclusion Criteria:

          -  Excluded will be those patients who have known sensitivity or allergy to mupirocin
             ointment, or patients using topical ocular or systemic antibiotics during a two week
             period prior to entry into the study. Additionally, patient's using topical
             corticosteroids will be excluded as well
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seenu Hariprasad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago Hospitals</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991 Dec;98(12):1769-75.</citation>
    <PMID>1775308</PMID>
  </reference>
  <reference>
    <citation>Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005 Feb;33(1):3-8. Review.</citation>
    <PMID>15750752</PMID>
  </reference>
  <reference>
    <citation>Ariyasu RG, Nakamura T, Trousdale MD, Smith RE. Intraoperative bacterial contamination of the aqueous humor. Ophthalmic Surg. 1993 Jun;24(6):367-73; discussion 373-4.</citation>
    <PMID>8336886</PMID>
  </reference>
  <reference>
    <citation>Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG, Holley HP Jr, Marsh RJ, Pfaller MA, McGowan JE Jr, Scully BE, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis. 1993 Sep;17(3):466-74.</citation>
    <PMID>8218691</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2006</study_first_submitted>
  <study_first_submitted_qc>November 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2006</study_first_posted>
  <last_update_submitted>September 4, 2013</last_update_submitted>
  <last_update_submitted_qc>September 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Endophthalmitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mupirocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

